DDMAC warning and untitled letters in 2008 total 21

Share this article:

The FDA's Division of Drug Marketing, Advertising and Communications issued 21 warning and untitled letters in 2008 – scarcely more than the 20 letters the unit sent out in 2007.

As in 2007, 10 were “warning letters,” the remainder being of the somewhat less serious “untitled” variety.

In 2006, DDMAC issued 22 letters reprimanding drug manufacturers for promotional materials deemed violative of the Food, Drug and Cosmetics Act, typically for overstating efficacy and/or underplaying risks, but 14 of those were warning letters.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.

Consultants expect M&A tempo to continue

Consultants expect M&A tempo to continue

PwC anticipates that divestitures will fuel late-2014 deals, but notes that the noise around early deals and the financials don't fully match up.